ATE146970T1 - Behandlung von entzündungen - Google Patents

Behandlung von entzündungen

Info

Publication number: ATE146970T1
Authority: AT; Austria
Prior art keywords: treatment; inflammation; cells; mast; mediators
Prior art date: 1990-10-16

Application number

AT91920172T

Other languages

English (en)

Inventor

John Lezdey

Allan Wachter

Original Assignee

John Lezdey

Allan Wachter

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-16

Filing date

1991-09-26

Publication date

1997-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27416749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE146970(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-04-11 Priority claimed from US07/683,620 external-priority patent/US5190917A/en

1991-09-26 Application filed by John Lezdey, Allan Wachter filed Critical John Lezdey

1997-01-15 Application granted granted Critical

1997-01-15 Publication of ATE146970T1 publication Critical patent/ATE146970T1/de

Links

238000011282 treatment Methods 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 title 1
230000004054 inflammatory process Effects 0.000 title 1
208000027418 Wounds and injury Diseases 0.000 abstract 2
230000006378 damage Effects 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
210000003630 histaminocyte Anatomy 0.000 abstract 2
208000014674 injury Diseases 0.000 abstract 2
229940122055 Serine protease inhibitor Drugs 0.000 abstract 1
101710102218 Serine protease inhibitor Proteins 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000003001 serine protease inhibitor Substances 0.000 abstract 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nanotechnology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Zoology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT91920172T 1990-10-16 1991-09-26 Behandlung von entzündungen ATE146970T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US59824190A	1990-10-16	1990-10-16
US64372791A	1991-01-18	1991-01-18
US07/683,620 US5190917A (en)	1986-12-24	1991-04-11	Treatment of psoriasis

Publications (1)

Publication Number	Publication Date
ATE146970T1 true ATE146970T1 (de)	1997-01-15

Family

ID=27416749

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91920172T ATE146970T1 (de)	1990-10-16	1991-09-26	Behandlung von entzündungen

Country Status (10)

Country	Link
EP (1)	EP0512090B2 (de)
AT (1)	ATE146970T1 (de)
AU (1)	AU679165B2 (de)
CA (1)	CA2091354C (de)
DE (1)	DE69123960T2 (de)
DK (1)	DK0512090T4 (de)
ES (1)	ES2096665T3 (de)
GR (1)	GR3022533T3 (de)
OA (1)	OA09768A (de)
WO (1)	WO1992006706A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4244735A1 (de) *	1992-08-24	1994-03-31	Behringwerke Ag	Verwendung von C1-Inaktivator zur Bekämpfung von Komplikationen bei der Anwendung von Zytokinen, endogenen Mediatoren, gentechnisch produzierten Mediator-Hybriden oder Wachstumsfaktoren im Rahmen der therapeutischen Anwendung dieser Substanzen
US5837699A (en)	1994-01-27	1998-11-17	Schering Corporation	Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5939525A (en) *	1995-03-27	1999-08-17	Viron Therapeutics, Inc.	Methods of treating inflammation and compositions therefor
US5614198A (en) *	1995-07-25	1997-03-25	The Trustees Of The University Of Pennsylvania	Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
DE19600480A1 (de) *	1996-01-09	1997-07-10	Beiersdorf Ag	Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
US5780440A (en) *	1996-06-17	1998-07-14	Protease Sciences Inc.	Treatment of pulmonary disease with protease inhibitors
EP0834556A1 (de) *	1996-09-25	1998-04-08	Academisch Ziekenhuis Leiden	Verfahren zur Zellkultivierung
GB2318732A (en)	1996-11-01	1998-05-06	Johnson & Johnson Medical	Wound healing compositions containing alpha-1-antitrypsin
US6344189B1 (en) *	1998-04-01	2002-02-05	Biotech Australia Pty., Ltd.	Use of protease inhibitors for treating skin wounds
EP1163900A1 (de) *	1998-11-05	2001-12-19	Protease Sciences, Incorporated	Kosmetische Zubereitung human-typische Serin-Protease-Inhibitoren enthaltend
EP1150699A4 (de) *	1999-02-01	2004-06-30	John Lezdey	Behandlung der blasen- und gastrointestinalen-mastozytose
EP1162934A4 (de) *	1999-02-22	2005-01-26	Eric F Bernstein	Zusammensetzungen und vefahren zur vorbeugung von lichtalterung
AU7957700A (en)	1999-10-26	2001-05-08	Japan Tissue Engineering Co., Ltd.	Wound contraction inhibitors
DE60020727T2 (de)	1999-10-27	2006-05-04	Robert London Zhong	Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AU2001241913A1 (en) *	2000-03-01	2001-09-12	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods for wound treatment
AU2001291579B2 (en)	2000-09-29	2006-08-31	Viron Therapeutics Inc.	Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
EP1392354B1 (de) *	2001-04-30	2005-03-09	Switch Biotech Aktiengesellschaft	Verwendung von alpha-1 antichymotrypsin zur herstellung von einer zusammensetzung zur behandlung, vorbeugung oder diagnose von schwerheilenden diabätische wunden
JP2005503772A (ja) *	2001-05-02	2005-02-10	センターフォーブラッドリサーチインコーポレイテッド	エラスターゼインヒビター分泌のモジュレータ
GB0125594D0 (en) *	2001-10-25	2001-12-19	Univ Sheffield	Inhibitors for inactivating allergens
EP1415664A1 (de) *	2002-10-30	2004-05-06	Switch Biotech Aktiengesellschaft	Verwendung von Alpha-1-antichymotrypsin in Kombination mit Alpha-1-antitrypsin zur Behandlung/Vorbeugung von schlecht heilenden arteriellen oder diabetischen Wunden
CA2506839A1 (en) *	2002-11-20	2004-06-03	Prometic Biosciences, Inc.	Composition and method for treating inflammatory diseases using protease inhibitors
US7850970B2 (en) *	2003-08-26	2010-12-14	The Regents Of The University Of Colorado	Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
WO2005056044A1 (en) *	2003-10-23	2005-06-23	Terry Du Clos	Use of c-reactive protein to treat immune complex-mediated renal disease
GB0411145D0 (en) *	2004-05-19	2004-06-23	Imp College Innovations Ltd	Protease inhibitors and their therapeutic applications
WO2005115385A1 (en) *	2004-05-24	2005-12-08	Ab Science	Use of c-kit inhibitors for treating acne
US7285530B2 (en)	2004-10-21	2007-10-23	Viron Therapeutics, Inc.	Use of SERP-1 as an antiplatelet agent
EP2069377A4 (de) *	2006-09-27	2009-11-11	Univ California	Verfahren und zusammensetzungen zur behandlung von hautkrankheiten und hautfunktionsstörungen
WO2012029061A2 (en)	2010-08-31	2012-03-08	Uri Wormser	POLYPEPTIDES DERIVED FROM α-1 ANTITRYPSIN AND METHODS OF USE THEREOF
US9518107B2 (en)	2010-08-31	2016-12-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.	Pharmaceutical compositions containing polypeptides derived from α-1 antitrypsin and methods of use thereof
WO2012178102A2 (en)	2011-06-24	2012-12-27	The Regents Of The Unversity Of Colorado, A Body Corporate	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
CA2896951A1 (en)	2012-01-10	2013-07-18	The Regents Of The University Of Colorado, A Body Corporate	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
JP2015517469A (ja) *	2012-05-01	2015-06-22	デユーク・ユニバーシテイ	移植片拒絶のバイオマーカーとしてのヘパラン硫酸の組成物および方法
US10034921B2 (en)	2013-02-13	2018-07-31	Laboratoire Français Du Fractionnement Et Des Biotechnologies	Proteins with modified glycosylation and methods of production thereof
WO2014159771A1 (en) *	2013-03-13	2014-10-02	The Regents Of The University Of California	Prevention of rosacea inflammation
JP2019527227A (ja) *	2016-07-19	2019-09-26	アレートディスカバリーズインコーポレイテッド	マスト細胞活性関連障害の検出および処置のためのバイオマーカー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0304971B1 (de) †	1982-08-13	1998-02-04	ZymoGenetics, Inc.	Verfahren zur Herstellung eines Polypeptids mit der Proteasehemmenden Aktivität von Säugetier-alpha-1-Antitrypsin
AU3145184A (en) *	1983-08-16	1985-02-21	Zymogenetics Inc.	High expression of foreign genes in schizosaccharomyces pombe
US5008242A (en) *	1986-12-24	1991-04-16	John Lezdey	Treatment of inflammation using 1-antichymotrypsin
US5093316A (en) †	1986-12-24	1992-03-03	John Lezdey	Treatment of inflammation
US4916117A (en) *	1986-12-24	1990-04-10	John Lezdey	Treatment of inflammation using alpha 1-antichymotrypsin
JP2656944B2 (ja) †	1987-04-30	1997-09-24	クーパーラボラトリーズ	タンパク質性治療剤のエアロゾール化

1991
- 1991-09-26 AT AT91920172T patent/ATE146970T1/de not_active IP Right Cessation
- 1991-09-26 CA CA002091354A patent/CA2091354C/en not_active Expired - Lifetime
- 1991-09-26 DK DK91920172T patent/DK0512090T4/da active
- 1991-09-26 AU AU89290/91A patent/AU679165B2/en not_active Ceased
- 1991-09-26 EP EP91920172A patent/EP0512090B2/de not_active Expired - Lifetime
- 1991-09-26 ES ES91920172T patent/ES2096665T3/es not_active Expired - Lifetime
- 1991-09-26 DE DE69123960T patent/DE69123960T2/de not_active Expired - Fee Related
- 1991-09-26 WO PCT/US1991/006847 patent/WO1992006706A1/en not_active Ceased
1992
- 1992-11-10 OA OA60300A patent/OA09768A/en unknown
1997
- 1997-02-12 GR GR970400221T patent/GR3022533T3/el unknown

Also Published As

Publication number	Publication date
CA2091354C (en)	2005-04-12
ES2096665T3 (es)	1997-03-16
AU679165B2 (en)	1997-06-26
WO1992006706A1 (en)	1992-04-30
CA2091354A1 (en)	1992-04-17
DK0512090T3 (da)	1997-06-16
EP0512090A4 (en)	1993-05-05
DK0512090T4 (da)	2007-01-15
DE69123960T2 (de)	1997-05-07
OA09768A (en)	1993-11-30
EP0512090A1 (de)	1992-11-11
EP0512090B1 (de)	1997-01-02
EP0512090B2 (de)	2006-11-22
GR3022533T3 (en)	1997-05-31
DE69123960D1 (de)	1997-02-13
AU8929091A (en)	1992-05-20

Legal Events

Date	Code	Title
1997-05-15	UEP	Publication of translation of european patent specification
2007-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties
2007-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE146970T1 (de)	1997-01-15	Behandlung von entzündungen
ES2078570T3 (es)	1995-12-16	Derivados de n-acil-alfa-aminoacidos.
EA200101166A1 (ru)	2002-06-27	Ингибиторы металлопротеаз
DK0380367T3 (da)	1994-02-28	Præparater og fremgangsmåde til sygdomsbehandling
PT92821A (pt)	1990-07-31	Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
MX9204703A (es)	1993-12-01	Acidos n-acil-n-heterociclilalquilamino, proceso para su obtencion y composicion farmaceutica que los contiene.
DK0432117T3 (da)	1994-07-25	Farmaceutisk præparat til behandling af inflammation
ATE80302T1 (de)	1992-09-15	Verwendung von polymeren bei einer behandlung.
ES2058125T3 (es)	1994-11-01	Derivados de piperidina para el tratamiento del dolor.
ES2118708T3 (es)	1998-10-01	Composiciones de piperidina y su preparacion y utilizacion.
ES2114117T3 (es)	1998-05-16	Acidos fenilalcan(en)oicos con actividad antagonista del leucotrieno b4.
ATE81004T1 (de)	1992-10-15	Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES2032922T3 (es)	1993-03-01	Empleo de los paf-aceter antagonicos para la fabricacion de un medicamento y procedimiento para determinar la eficacia de los mismos.
ATE126061T1 (de)	1995-08-15	Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
DE69108748D1 (de)	1995-05-18	Antithrombin-Lösung und ihre Verwendung.
ES8801173A1 (es)	1988-01-01	Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
MX9403032A (es)	1995-01-31	Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
ES2064983T3 (es)	1995-02-01	Dispositivo para el tratamiento termico y/o humectacion de carretes, canillas y conos.
ES2166838T3 (es)	2002-05-01	6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
ES252138Y (es)	1981-04-16	Zapato ortopedico perfeccionado con punta automaticamente elevable al levantar el pie
ES2036533T3 (es)	1993-06-01	Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
SE8902607D0 (sv)	1989-07-27	Oxaza heterocycles and pharmaceutical compositions containing same
ITMI920979A1 (it)	1993-10-24	N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
ES2060675T3 (es)	1994-12-01	Imidazobenzodiacepina eficaz como antipsicotico.
ES517341A0 (es)	1983-11-01	Prensa hidraulica embaladora automatica y autodesinfectable para la eliminacion y el tratamiento en condiciones higienicas adecuadas de los residuos clinicos y hospitalarios infectados.